Research Papers
Antimicrobial Peptides (AMPs) in Research: Mechanisms and Pipeline
⚠FOR LABORATORY RESEARCH AND EDUCATIONAL PURPOSES ONLY — NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Quick answer: Antimicrobial peptides (AMPs), also called host-defense peptides, are short peptides that many organisms produce as part of innate immunity against bacteria, viruses, and fungi. Because they disrupt microbial memb...
Collagen Peptide Research: Pro-Hyp, GHK-Cu and Matrix Pathways
⚠FOR LABORATORY RESEARCH AND EDUCATIONAL PURPOSES ONLY — NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Quick answer: Collagen peptide research covers two distinct areas that are often confused. The first is dietary hydrolysed collagen, where studies have examined whether specific fragments such as Pro-Hyp survive digestion. The ...
GLP-1 Weight Loss and Body Composition: What Research Shows About Lean Mass
âš FOR EDUCATIONAL AND SCIENTIFIC REFERENCE PURPOSES ONLY. THIS ARTICLE SUMMARISES PUBLISHED CLINICAL LITERATURE AND IS NOT MEDICAL ADVICE.
Quick answer: Body composition studies report that lean soft tissue accounts for roughly 20–40% of total weight reduction during GLP-1 receptor agonist treatment, measured by DXA. How...
PT-141 (Bremelanotide) Research: Melanocortin Receptor Pathways
⚠FOR LABORATORY RESEARCH AND EDUCATIONAL PURPOSES ONLY — NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Quick answer: PT-141 (bremelanotide) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) that acts as a melanocortin receptor agonist, with research focus on the MC3R and MC4R subtypes ex...
PATH TO PEPTIDES GROWTH HORMONE PEPTIDES
PATH TO PEPTIDES GROWTH HORMONE PEPTIDES:
WHAT THE RESEARCH SAYS
Quick answer: Growth hormone peptides are research compounds studied for their effects on the growth hormone axis. Growth hormone secretagogues such as CJC-1295 (a GHRH analog) and ipamorelin (a ghrelin-receptor agonist) are investigated in vitro for ...
PATH TO PEPTIDES “OZEMPIC BABIES”
PATH TO PEPTIDES "OZEMPIC BABIES":
WHAT SCIENCE SAYS ABOUT GLP-1 AND FERTILITY
Prescriptions for women with PCOS surged 637%. Thousands report unexpected pregnancies. Here's what researchers know so far.
GLP-1 PRESCRIPTIONS FOR WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS) INCREASED 637% BETWEEN 2020 AND 2024. THOUSANDS OF...
KLOW Peptide Blend Research: GHK-Cu, BPC-157, TB-500 and KPV
⚠FOR LABORATORY RESEARCH AND EDUCATIONAL PURPOSES ONLY — NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Quick answer: The KLOW peptide blend is a four-component research formulation combining GHK-Cu (a copper-binding tripeptide), BPC-157, TB-500, and KPV. Each component has been studied independently in preclinical models across ...
GLP-1 Receptor Agonists and the Brain: What the EVOKE Trials Revealed
âš FOR EDUCATIONAL AND SCIENTIFIC REFERENCE PURPOSES ONLY. THIS ARTICLE SUMMARISES PUBLISHED CLINICAL LITERATURE AND IS NOT MEDICAL ADVICE.
Quick answer: The EVOKE and EVOKE+ phase 3 trials — the largest and longest GLP-1 studies ever conducted in a neurodegenerative disease, enrolling 3,808 participants over two years — ...
Peptide Blueprint VOL2 Issue24 GLP-1 & Heart Health & Brain combine
PATH TO PEPTIDES GLP-1 AND YOUR HEART
WHAT A 2-MILLION-PATIENT STUDY REVEALED
A STUDY OF OVER 2 MILLION PATIENTS FOUND THAT GLP-1 DRUGS WERE LINKED TO LOWER RISK OF 42 DIFFERENT HEALTH CONDITIONS — INCLUDING HEART ATTACK, STROKE, AND HEART FAILURE.
Quick answer: A study of over 2 million patients found GLP-1 drugs...
PATH TO PEPTIDES: GLP-1 AND YOUR HEART
PATH TO PEPTIDES GLP-1 AND YOUR HEART
WHAT A 2-MILLION-PATIENT STUDY REVEALED
A STUDY OF OVER 2 MILLION PATIENTS FOUND THAT GLP-1 DRUGS WERE LINKED TO LOWER RISK OF 42 DIFFERENT HEALTH CONDITIONS — INCLUDING HEART ATTACK, STROKE, AND HEART FAILURE.
Quick answer: A study of over 2 million patients found GLP-1 drugs...
